AACR Virtual Annual Meeting I: Showcasing Technological Advances in Adoptive Cell Transfer
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
“The field of cell therapy is one of the most exciting fields in translational medicine,” began Katayoun Rezvani, MD, PhD,...
A pair of studies presented at the AACR Annual Meeting 2019 demonstrated encouraging clinical outcomes with two different chimeric...
One of the most watched areas in the immuno-oncology field is the development of chimeric antigen receptor (CAR) T-cell...
In the 1970s television series The Six Million Dollar Man, the narrator says of severely injured astronaut Steve Austin:...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved expanding the use of the immunotherapeutic tisagenlecleucel (Kymriah)...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a revolutionary new type of immunotherapy...